TherapeuticsMD (TXMD) Preferred Dividend Payments (2012 - 2013)
TherapeuticsMD (TXMD) posted Preferred Dividend Payments of $1.1 million for Q2 2013, up 115.7% on a QoQ basis from -$6.7 million in Q2 2012, and up 115.7% year-over-year from $488936.3 in Q2 2012.
TherapeuticsMD (TXMD) Preferred Dividend Payments (2012 - 2013) Analysis & Trends
TherapeuticsMD's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $1.1 million for Q2 2013.
- Quarterly Preferred Dividend Payments rose 115.7% year-over-year to $1.1 million in Q2 2013, while the trailing twelve-month figure through Jun 2013 was -$5.7 million (changed N/A YoY) and the FY2012 annual result came in at -$6.7 million, changed N/A from the prior year.
- Preferred Dividend Payments was $1.1 million for Q2 2013 at TherapeuticsMD, up from -$6.7 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $1.1 million in Q2 2013 and bottomed at -$6.7 million in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | TherapeuticsMD | 278,799.99 | -8.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 1.05 Mn |
| Jun 30, 2012 | -6.72 Mn |